StephenShiu-WahChungMD

PubMed

• Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.
  Mohammad Faizan Zahid, Kelsey Moriarty, Courtney Dryden, Olga Weinberg, Misha Asif, Ruth Ikpefan, Julia M Anderson, Robert H Collins, Stephen S Chung, Weina Chen, Prap...> ;European Journal of Haematology. 2023 Dec 1
• 6 citations
  Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation.
  Yafeng Li, Jessica S Hook, Qing Ding, Xue Xiao, Stephen S Chung, Marcel Mettlen, Lin Xu, Jessica G Moreland, Michalis Agathocleous> ;Nature Communications. 2023 May 5
• Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience.
  Fieke W Hoff, Stephen S Chung, Prapti A Patel, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Selamawit Yohannes, Jaime Shahan, He...> ;Transplant Immunology. 2023 Apr 1
• 4 citations
  Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.
  Junhua Lyu, Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F Madanat, Yuannyu Zhang, Feng Cai, Zhimin Gu, Hui Cao, Pranita Kaphle, Yoon Jung Kim, Fatma N Kalkan, Helen Step...> ;Cancer Discovery. 2023 Jan 9
• Distinct mutational and clinicopathologic profiles characterize acute myeloid leukemia with cup-like nuclei.
  Estelle Oertling, Franklin Fuda, Prasad Koduru, Mingyi Chen, Olga Weinberg, Marisa Juntilla, Jesse Jaso, Madhuri Vusirikala, Stephen Chung, Praveen Ramakrishnan Geetha...> ;Leukemia Research. 2023 Jan 1
• 5 citations
  Convergence of oncogenic cooperation at single-cell and single-gene levels drives leukemic transformation
  Yuxuan Liu, Zhimin Gu, Hui Cao, Pranita Kaphle, Junhua Lyu, Yuannyu Zhang, Wenhuo Hu, Stephen Chung, Kathryn E. Dickerson, Jian Xu> ;Nature Communications. 2021 Nov 3
• Corrigendum to "The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement" [L...
  Colin P. Bergstrom, Saurabh Dahiya, Weina Chen, Cheng Cheng Zhang, Hong Zhu, Jingsheng Yan, Yazan F. Madanat, Prapti A. Patel, Madhuri Vusirkala, Praveen Ramakrishnan,...> ;Leukemia Research. 2021 Mar 26
• 5 citations
  The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement.
  Colin P. Bergstrom, Saurabh Dahiya, Weina Chen, Cheng Cheng Zhang, Hong Zhu, Jingsheng Yan, Yazan F. Madanat, Prapti A. Patel, Madhuri Vusirkala, Praveen Ramakrishnan,...> ;Leukemia Research. 2021 Jan 1
• 8 citations
  Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-cent...
  Justin Taylor, Xiaoli Mi, Alexander V Penson, Stella V Paffenholz, Kelsey Alvarez, Allison Sigler, Stephen S. Chung, Raajit K. Rampal, Jae H. Park, Eytan M. Stein, Mar...> ;The Lancet. Haematology. 2020 Aug 1
• 21 citations
  CD97 is a critical regulator of acute myeloid leukemia stem cell function.
  Gaëlle H. Martin, Nainita Roy, Sohini Chakraborty, Alexis Desrichard, Stephen S. Chung, Carolien M. Woolthuis, Wenhuo Hu, Iryna berezniuk, Francine E. Garrett-Bakelman...> ;The Journal of Experimental Medicine. 2019 Oct 7
• 40 citations
  Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies.
  Justin Taylor, Dean Pavlick, Akihide Yoshimi, Christina Marcelus, Stephen S. Chung, Jaclyn F. Hechtman, Ryma Benayed, Emiliano Cocco, Benjamin H. Durham, Lillian Bitne...> ;The Journal of Clinical Investigation. 2018 Aug 31
• 4 citations
  Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes
  Montreh Tavakkoli, Stephen S. Chung, Christopher Y. Park> ;Expert Opinion on Therapeutic Targets. 2018 Apr 20
• 9 citations
  Aging, hematopoiesis, and the myelodysplastic syndromes.
  Stephen S Chung, Christopher Y Park> ;Blood Advances. 2017 Dec 12
• 6 citations
  Aging, hematopoiesis, and the myelodysplastic syndromes.
  Stephen S Chung, Christopher Y Park> ;Hematology. American Society of Hematology. Education Program. 2017 Dec 8
• 68 citations
  Genomic Analysis of Hairy Cell Leukemia Identifies Novel Recurrent Genetic Alterations
  Benjamin H. Durham, Bartlomiej Getta, Sascha Dietrich, Justin Taylor, Helen Won, James M Bogenberger, Sasynia N Scott, Eunhee Kim, Young Rock Chung, Stephen S. Chung, ...> ;Blood. 2017 Oct 5
• 97 citations
  CD99 is a therapeutic target on disease stem cells in myeloid malignancies.
  Stephen S. Chung, William S. Eng, Wenhuo Hu, Mona Khalaj, Francine E. Garrett-Bakelman, Montreh Tavakkoli, Ross L. Levine, Martin Carroll, Virginia M. Klimek, Ari Meln...> ;Science Translational Medicine. 2017 Jan 25
• 253 citations
  Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
  Sheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung, Mathijs A. Sanders, Todd Hricik, Franck Rapaport, Jay P. Patel, Richard Dillon, Priyanka Vijay, Anna L. Brown...> ;Nature Medicine. 2016 Jul 1
• Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?
  Stephen S. Chung> ;Current Opinion in Hematology. 2016 Mar 1
• 46 citations
  CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Gra...
  Roni Tamari, Stephen S. Chung, Esperanza B. Papadopoulos, Ann A. Jakubowski, Patrick Hilden, Sean M. Devlin, Jenna D. Goldberg, Miguel-Angel Perales, Doris M. Ponce, C...> ;Biology of Blood and Marrow Transplantation. 2015 Dec 1
• 215 citations
  Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
  Enrico Tiacci, Jae H. Park, L. De Carolis, Stephen S. Chung, Alessandro Broccoli, Sasinya N. Scott, Francesco Zaja, Sean M. Devlin, Alessandro Pulsoni, Young Rock Chun...> ;The New England Journal of Medicine. 2015 Oct 28
• 59 citations
  miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a.
  Wenhuo Hu, James Dooley, Stephen S. Chung, Dhruva Chandramohan, Luisa Cimmino, Siddhartha Mukherjee, Christopher E. Mason, Bart De Strooper, Adrian Liston, Christopher...> ;Blood. 2015 Apr 2
• 85 citations
  Hematopoietic Stem Cell Origin of BRAFV600E Mutations in Hairy Cell Leukemia
  Stephen S. Chung, Eunhee Kim, Jae H. Park, Young Rock Chung, Piro Lito, Julie Teruya-Feldstein, Wenhuo Hu, Wendy Béguelin, Sebastien Monette, Cihangir Duy, Raajit K. R...> ;Science Translational Medicine. 2014 May 28
• 7 citations
  Genetic mutations in acute myeloid leukemia that influence clinical decisions.
  Stephen S. Chung> ;Current Opinion in Hematology. 2014 Mar 1
• 1783 citations
  Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
  Marco L. Davila, Isabelle Riviere, Xiuyan Wang, Shirley Bartido, Jae H. Park, Kevin J. Curran, Stephen S. Chung, Jolanta Stefanski, Oriana Borquez-Ojeda, Malgorzata Ol...> ;Science Translational Medicine. 2014 Feb 19
• 97 citations
  Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.
  Alan H. Shih, Stephen S. Chung, Emily K. Dolezal, Su Jiang Zhang, Omar Abdel-Wahab, Christopher Y. Park, Stephen D. Nimer, Ross L. Levine, Virginia M. Klimek> ;Haematologica. 2013 Jun 1
• Join now to see all

Journal Articles

• CD99 is a Therapeutic Target on Disease Stem Cells in Myeloid Malignancies  
  Chung SS, Eng WS, Hu W, Khalaj M, Garrett-Bakelman FE, Tavakkoli M, Levine RL, Carroll M, Klimek VM, Melnick AM, Park CY, Sci Transl Med, 1/1/2017
• MicroRNA Dysregulation in the Myelodysplastic Syndromes  
  Chung SS, Park CY, MicroRNA, 1/1/2013
• A 75- year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)  
  Baikaidi M, Chung SS, Tallman MS, Damon LE, Walker AR, Marcucci G, Sholi AM, Morris GJ, Semin Oncol, 1/1/2012
• The Role of MicroRNAs in Hematopoietic Stem Cell and Leukemic Stem Cell Function  
  Chung SS, Hu W, Park CY, Therapeutic Advances in Hematology, 1/1/2011
• Cardiac Transplantation Followed by Dose-Intensive Melphalan and Autologous Stem Cell Transplantation for AL Amyloidosis and Heart Failure  
  Dey BR, Chung SS, Spitzer TR, Zheng H, MacGillivray TE, Seldin DC, McAfee S, Ballen KK, Attar E, Wang T, Shin J, Newton-Cheh C, Moore S, Sanchorawala V, Skinner M, Mad..., Transplantation, 1/1/2010
• Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-beta-glucosidase  
  Steet R, Chung S, Lee WS, Pine CW, Do H, Kornfeld S, Biochem Pharmacol, 1/1/2007
• The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms  
  Steet RA, Chung S, Wustman B, Powe A, Do H, Kornfeld SA, PNAS, 1/1/2006
• Join now to see all

Books/Book Chapters

• Cancer Stem Cells. 
  Chapter: Acute Myeloid Leukemia Stem Cells�Updates and Controversies. Chapter 11 
  Chung SS, Park CYWiley2014

Lectures

• An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution. 
  1/1/2017
• An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution. Session 636. Myelodysplastic Syndromes- Basic... 
  1/1/2016
• CD99 is a Therapeutic Target on Disease Stem Cells in the Myelodysplastic Syndromes and Acute Myeloid Leukemia. Session 6: The Myelodysplastic Syndromes. 
  1/1/2014
• BRAFV600E Mutations Occur In The Hematopoietic Stem Cell Compartment In Hairy Cell Leukemia. Session 603. Oncogenes and Tumor Suppressors: Molecular Pathogenesis of L... 
  1/1/2013
• CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia (AML) and the Myelodysplastic Syndromes (MDS). Session 9: Leukemia. 
  1/1/2013
• CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes. Session 661. Malignant Stem and Progenitor Cells. 
  1/1/2012
• Join now to see all